Navigation Links
Genomatix wins the 'INDUSTRIEPREIS 2012' in the biotech category at Hannover Messe

Munich, Germany, April 27th, 2012 - Genomatix is proud to announce that it has been awarded the "INDUSTRIEPREIS 2012" in the biotech category at Hannover Messe, the world's biggest technology trade show. The INDUSTRIEPREIS is awarded in 14 categories to companies for products of a high technological, economic, ecological or social value. Nominees and winners are chosen by a panel of 30 experts including professors and specialized journalists. Genomatix has received the INDUSTRIEPREIS for its data analysis and interpretation platform Genomatix Genome Analyzer (GGA).

"We're really proud to have received this award for a data analysis solution", says Dr. Korbinian Grote, product manager at Genomatix. "Usually the focus on big technology fairs is more on lab equipment providers, in our field the sequencer manufacturers stand out with ever new records of gigabases of DNA data they can produce. But researchers also need solutions to analyze and interpret these data to extract the information from it and generate new biomedical knowledge." "Being appreciated for our data analysis solutions is certainly a big motivation for the whole team to come up with even more innovative ideas on how to deal with the increasing deluge of Next Generation Sequencing data", adds Dr. Martin Seifert, CEO of Genomatix, "getting an award that explicitly rewards products of technological and social value underlines that NGS is quickly moving from a research tool into the broader field of clinical application."

Contact: Korbinian Grote
Genomatix Software GmbH

Page: 1

Related biology news :

1. Genomatix to partner in $41 million European epigenomics consortium
2. Genomatix wins "Most Creative Visualization" award at iDEA Challenge 2011
3. Genomatix, USU and HJF execute a CRADA: Prostate cancer prognostic marker discovery by NGS
4. Eurofins MWG Operon and Genomatix developed most complete human exome array
5. Eurofins MWG Operon and Genomatix launch strategic alliance
6. Genomatix gives a hand in the analysis of Wayne States sequencing projects
7. University of Michigan installs second Genomatix Genome Analyzer
8. MCTP bought Genomatix NextGen Sequencing analysis stations
9. Genomatix gets patent for comparative genomics method
10. CRG buys Genomatix Next Generation Sequencing analysis solution
11. Boehringer Ingelheim uses Genomatix Next Generation Sequencing data analysis systems
Post Your Comments:
Related Image:
Genomatix wins the 'INDUSTRIEPREIS 2012' in the biotech category at Hannover Messe
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology: